Mycophenolate Sodium
Mycophenolate Sodium is an active ingredient in 41 FDA-listed drug products sold under 2 names.
Drugs containing Mycophenolate Sodium
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 50090-6492 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | A-S Medication Solutions |
| 16729-261 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Accord Healthcare Inc. |
| 16729-189 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Accord Healthcare Inc. |
| 72888-199 | mycophenolic acid Tablet, Delayed Release | 180 mg/1 | Advagen Pharma Limited |
| 72888-200 | mycophenolic acid Tablet, Delayed Release | 360 mg/1 | Advagen Pharma Limited |
| 68084-918 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | American Health Packaging |
| 68084-907 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | American Health Packaging |
| 60505-2965 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Apotex Corp |
| 60505-2966 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Apotex Corp |
| 67877-929 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Ascend Laboratories, LLC |
| 67877-426 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Ascend Laboratories, LLC |
| 67877-928 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Ascend Laboratories, LLC |
| 67877-427 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Ascend Laboratories, LLC |
| 59651-621 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Aurobindo Pharma Limited |
| 59651-622 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Aurobindo Pharma Limited |
| 70377-040 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Biocon Pharma Inc. |
| 70377-127 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Biocon Pharma Inc. |
| 70377-039 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Biocon Pharma Inc. |
| 70377-126 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Biocon Pharma Inc. |
| 68254-5001 | mycophenolic acid Tablet, Delayed Release | 180 mg/1 | CONCORD BIOTECH LIMITED |
| 68254-5002 | mycophenolic acid Tablet, Delayed Release | 360 mg/1 | CONCORD BIOTECH LIMITED |
| 60429-017 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Golden State Medical Supply, Inc. |
| 60429-016 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Golden State Medical Supply, Inc. |
| 0904-7372 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Major Pharmaceuticals |
| 0904-6786 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Major Pharmaceuticals |
| 0904-6785 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Major Pharmaceuticals |
| 66828-0289 | mycophenolic acid Tablet, Delayed Release | 180 mg/1 | Novartis Pharma Produktions GmbH |
| 66828-0296 | mycophenolic acid Tablet, Delayed Release | 360 mg/1 | Novartis Pharma Produktions GmbH |
| 82293-012 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Novugen Pharma (USA) LLC. |
| 82293-013 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Novugen Pharma (USA) LLC. |
| 72789-247 | mycophenolic acid Tablet, Delayed Release | 180 mg/1 | PD-Rx Pharmaceuticals, Inc. |
| 72789-246 | mycophenolic acid Tablet, Delayed Release | 360 mg/1 | PD-Rx Pharmaceuticals, Inc. |
| 70518-4391 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | REMEDYREPACK INC. |
| 70436-172 | Mycophenolic Acid Tablet, Delayed Release | 180 mg/1 | Slate Run Pharmaceuticals, LLC |
| 70436-173 | Mycophenolic Acid Tablet, Delayed Release | 360 mg/1 | Slate Run Pharmaceuticals, LLC |
| 85972-161 | mycophenolic acid Tablet, Delayed Release | 180 mg/1 | Stellon Biotech Inc. |
| 85972-162 | mycophenolic acid Tablet, Delayed Release | 360 mg/1 | Stellon Biotech Inc. |
| 24979-160 | mycophenolic acid Tablet, Delayed Release | 180 mg/1 | Upsher-Smith Laboratories, LLC |
| 24979-161 | mycophenolic acid Tablet, Delayed Release | 360 mg/1 | Upsher-Smith Laboratories, LLC |
| 0078-0385 | Myfortic Tablet, Delayed Release | 180 mg/1 | Novartis Pharmaceuticals Corporation |
| 0078-0386 | Myfortic Tablet, Delayed Release | 360 mg/1 | Novartis Pharmaceuticals Corporation |